Showing results (1-10 of 100) with videos related to
Sort By:
Pageof 10
The Canadian Journal of Cardiology|June 9, 2005
Have angiotensin receptor blockers lived up to expectations?David FitchettThe Canadian Journal of Cardiology|June 28, 2007
The impact of bleeding in patients with acute coronary syndromes: how to optimize the benefits of treatment and minimize the riskDavid FitchettExpert Review of Cardiovascular Therapy|August 1, 2008
Tailored antithrombotic therapy for acute coronary syndromesDavid FitchettVascular Health and Risk Management|May 14, 2009
Results of the ONTARGET and TRANSCEND studies: an update and discussionDavid FitchettDiabetes, Obesity & Metabolism|May 14, 2019
A safety update on sodium glucose co-transporter 2 inhibitorsDavid FitchettVascular Health and Risk Management|January 19, 2008
Clinical trial update: focus on the ONTARGET studyDavid FitchettThe Canadian Journal of Cardiology|March 19, 2015
The metabolic syndrome is an important concept in therapeutic decision-makingDavid FitchettAtherosclerosis. Supplements|March 7, 2006
Optimal care of cardiovascular disease and type 2 diabetes patients: shared responsibilities between the cardiologist and diabetologistLawrence A Leiter, David FitchettThe Canadian Journal of Cardiology|May 27, 2005
Enoxaparin and percutaneous coronary intervention: a Canadian perspectiveDavid Fitchett, Robert Welsh, Anatoly Langer, et al.The Canadian Journal of Cardiology|October 2, 2018
Diabetes Mellitus and Cardiovascular Disease: An Evidence-Based Review of Provincial Formulary CoverageShivraj S Riar, David Fitchett, Jeremy FitzGerald, et al.Pageof 10